|
Crohn's Disease is an inflammatory bowel disease which causes inflammation in the small intestine. It normally occurs in the lower part of the small intestine, the ileum, but can affect any part of the digestive tract. The inflammation extends deep into the lining of the affected organ, causing pain and diarrhoea.
Follow the links below to find information relating to Crohn's Disease.
Reviewed February 2009
Printer friendly page
| Results 1 to 20 displayed. |
|
1
2
|
| Title: |
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Azathioprine and 6-mercaptopurine may be effective for inducing remission in Crohn's disease among patients with chronically active disease. These drugs may reduce the need for steroid treatment and their use may therefore lead to a lower incidence of s...
|
| Date: |
Jul 2009
|
| Title: |
Crohn's disease - myDr.com.au
|
| Publisher: |
myDr
|
| Description: |
Crohn's disease is one of a group of conditions known as inflammatory bowel disorders.
|
| Date: |
Jul 2009
|
| Title: |
Methotrexate for maintenance of remission in Crohn's disease
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Crohn's disease is a chronic inflammatory disease of the intestines that frequently occurs in the lower part of the small intestine, called the ileum. However, Crohn's disease can affect any part of the digestive tract, from the mouth to the anus. The m...
|
| Date: |
Apr 2009
|
| Title: |
Interventions for prevention of post-operative recurrence of Crohn's disease
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Crohn's disease is a chronic illness where patients suffer from diarrhea, weight loss or stomach pain resulting from inflammation in the intestine. The illness often requires patients to undergo surgery in order to remove inflamed segments of intestine,...
|
| Date: |
Feb 2009
|
| Title: |
Thalidomide and thalidomide analogues for maintenance of remission in Crohn's disease
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Prevention of relapse is a key objective in the management of Crohn's disease. There is no current treatment available that completely maintains remission and is without significant side-effects. Thalidomide is sometimes used in clinical practice to att...
|
| Date: |
Sep 2008
|
| Title: |
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Azathioprine (1.0 to 2.5 mg/day) used among patients with non-active Crohn's disease is effective for reducing the risk of disease recurrence over a 6 month to 2 year period. Higher doses of azathioprine (2.5 mg/day) are more effective than lower doses ...
|
| Date: |
Aug 2008
|
| Title: |
Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Fish oil contains omega 3 fatty acids that may be beneficial in reducing inflammation, such as seen in the bowel of Crohn's disease patients. Randomized placebo-controlled studies that evaluated the effect of daily intake of capsules containing omega-3 ...
|
| Date: |
Aug 2008
|
| Title: |
Budesonide for maintenance of remission in Crohn's disease
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Budesonide is a newer corticosteroid drug which is rapidly metabolized by the liver thereby reducing corticosteroid related side effects. Research showing that budesonide is effective in treating active Crohn's disease has led to trials examining the e...
|
| Date: |
Aug 2008
|
| Title: |
Thalidomide and thalidomide analogues for induction of remission in Crohn's disease
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Crohn's disease is a chronic inflammatory disorder of the bowel. Thalidomide may help to reduce inflammation in the gut and might be effective for the treatment of Crohn's disease. One randomised controlled trial on the use of thalidomide for the treatm...
|
| Date: |
Aug 2008
|
| Title: |
Corticosteroids for maintenance of remission in Crohn's disease
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
The use of corticosteroids among patients with non-active Crohn's disease does not appear to be effective in reducing the risk of disease recurrence over a 24 month period. Side effects associated with the long term use of corticosteroids include osteop...
|
| Date: |
Jul 2008
|
| Title: |
Probiotics for induction of remission in Crohn's disease
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Crohn's disease is a chronic inflammatory disease of the intestines which has periods of inactivity and periods when it flares up. Crohn's disease can affect any part of the digestive tract, from the mouth to the anus. The most common symptoms of Cro...
|
| Date: |
Apr 2008
|
| Title: |
Crohn's disease (inflammatory bowel disease)
|
| Publisher: |
Virtual Medical Centre.com
|
| Description: |
Crohn's disease is a chronic and relapsing inflammatory disorder that can affect any part of the gastrointestinal tract, from the mouth to the anus, as well as other organs of the body. Crohn's disease is a type of inflammatory bowel disease. Provides information on the symptoms, diagnosis and treatment of the disease.
|
| Date: |
Feb 2008
|
| Title: |
Traditional corticosteroids for induction of remission in Crohn's disease
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Corticosteroids have been used for decades to treat active Crohn's disease. Controlled clinical studies that evaluated the effect of systemic corticosteroids to induce remission in Crohn's disease were reviewed. For inclusion in this analysis, studies c...
|
| Date: |
Feb 2008
|
| Title: |
Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Crohn's disease is a chronic inflammatory disease of the intestines. Crohn's disease frequently occurs in the lower part of the small intestine (the ileum), however it can affect any part of the digestive tract, from the mouth to the anus. The most comm...
|
| Date: |
Oct 2007
|
| Title: |
Enteral nutrition for maintenance of remission in Crohn's disease
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Crohn's disease is a chronic inflammatory disease of the intestines. Crohn's disease frequently occurs in the lower part of the small intestine (the ileum), however it can affect any part of the digestive tract, from the mouth to the anus. The most comm...
|
| Date: |
Apr 2007
|
| Title: |
Stapled versus handsewn methods for ileocolic anastomoses
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
After surgery for right-sided bowel cancer or Crohn's disease, the bowel ends may be joined either by the use of a stapler or by manual suturing. This systematic review found 6 randomised controlled trials with a total of 955 participants (357 stapled, ...
|
| Date: |
Mar 2007
|
| Title: |
Enteral nutritional therapy for induction of remission in Crohn's disease
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Evidence continues to indicate that corticosteroids are more effective than enteral nutrition (liquid food) for treating active Crohn's disease. Comparing one form of enteral nutrition to another has not shown any difference in effectiveness for treatin...
|
| Date: |
Oct 2006
|
| Title: |
Interventions for growth failure in childhood Crohn's disease
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Growth failure occurs in 15-40% of children with Crohn's disease. Growth in affected children is influenced by the disease process itself and by some treatments. Management in children differs from that in adults because of the required emphasis on achi...
|
| Date: |
May 2005
|
| Results 1 to 20 displayed. |
|
1
2
|
|
